SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported) – November 2, 2006
________________________
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
_____________________
|
|
|
|
|
Pennsylvania |
1-8036 |
23-1210010 |
|
(State or other jurisdiction |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
|
|
|
101 Gordon Drive, PO Box 645, Lionville, PA |
|
19341-0645 |
|
(Address of principal executive offices) |
|
(Zip Code) |
(610) 594-2900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02 |
Results of Operations and Financial Condition | |
|
|
| |
|
|
On November 2, 2006, West Pharmaceutical Services, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the third quarter ended September 30, 2006. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. | |
|
|
| |
| Item 9.01 |
Financial Statements, Pro Forma Financial Information and Exhibits. | |
|
|
| |
|
(c) |
Exhibits | |
|
|
| |
|
|
Exhibit # |
Description |
|
|
99.1 |
West Pharmaceutical Services, Inc. Press Release, dated November 2, 2006. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| WEST PHARMACEUTICAL SERVICES, INC. |
|
|
| /s/ William J. Federici |
| William J. Federici |
| Vice President and Chief Financial Officer |
November 2, 2006
EXHIBIT INDEX
Description
|
|
|
|
99.1 |
West Pharmaceutical Services, Inc. Press Release, dated November 2, 2006. |
|
|
|
|
|
|